• Title of article

    Exosomal tumor-suppressive microRNAs as novel cancer therapy: “Exocure” is another choice for cancer treatment

  • Author/Authors

    Kosaka، نويسنده , , Nobuyoshi and Takeshita، نويسنده , , Fumitaka and Yoshioka، نويسنده , , Yusuke and Hagiwara، نويسنده , , Keitaro and Katsuda، نويسنده , , Takeshi and Ono، نويسنده , , Makiko and Ochiya، نويسنده , , Takahiro، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2013
  • Pages
    7
  • From page
    376
  • To page
    382
  • Abstract
    MicroRNAs (miRNAs) act to fine-tune cellular responses in a variety of biological circumstances such as development, organogenesis, and homeostasis. The dysregulation of miRNA expression accelerates disease progression, including metabolic disease, immunological disease and cancer, through the gene network disorder. Therefore, understanding the miRNA maturation process may unravel the mechanisms of cancer malignancy; however, the life of miRNA has not been clarified. In this article, we summarize the recent findings regarding the novel forms of miRNA, especially secretory miRNAs, focusing on exosomal miRNAs. Recent research has revealed that exosomal miRNAs affect many aspects of physiological and pathological conditions, and may be useful as novel therapy. Here, we propose a method for the delivery of tumor-suppressive miRNAs to desired sites using exosomes, and we named this method “exocure”.
  • Keywords
    Cell–cell communication , Tumor initiation , Exosomes , Drug delivery system , Exosome , microvesicle , Tumor-suppressive microRNA , Secretory microRNAs , Small RNA therapy
  • Journal title
    Advanced Drug Delivery Reviews
  • Serial Year
    2013
  • Journal title
    Advanced Drug Delivery Reviews
  • Record number

    1763664